These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 12001119)

  • 1. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
    Glas AS; Hollema H; Nap RE; Plukker JT
    Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptor beta expression in pleomorphic adenomas of the parotid gland.
    Wong MH; Dobbins TA; Tseung J; Tran N; Lee CS; O'Brien CJ; Clark J; Rose BR
    J Clin Pathol; 2009 Sep; 62(9):789-93. PubMed ID: 19734474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.
    Stennert E; Wittekindt C; Klussmann JP; Arnold G; Guntinas-Lichius O
    Laryngoscope; 2004 Jan; 114(1):158-63. PubMed ID: 14710014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pleomorphic parotid adenomas and their recurrence].
    Federspil PA; Federspil P; Schätzle W
    HNO; 1994 Jan; 42(1):28-35. PubMed ID: 8150670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle.
    Marioni G; Marino F; Stramare R; Marchese-Ragona R; Staffieri A
    Head Neck; 2003 Dec; 25(12):1071-6. PubMed ID: 14648866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hormonal receptor in patients with metastasizing pleomorphic adenoma of the major salivary gland; a clinicopathological report of three cases.
    Larbcharoensub N; Cert PK; Tungkeeratichai J; Prakunhungsit S; Narkwong L; Leopairut J
    J Med Assoc Thai; 2009 Sep; 92(9):1250-5. PubMed ID: 19772187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients.
    Wittekindt C; Streubel K; Arnold G; Stennert E; Guntinas-Lichius O
    Head Neck; 2007 Sep; 29(9):822-8. PubMed ID: 17563905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pleomorphic adenoma of the parotid gland. Results of surgical treatment].
    Huber A; Schmid S; Fisch U
    HNO; 1994 Sep; 42(9):553-8. PubMed ID: 7989227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator.
    Koral K; Sayre J; Bhuta S; Abemayor E; Lufkin R
    AJR Am J Roentgenol; 2003 Apr; 180(4):1171-4. PubMed ID: 12646477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
    Soares AB; de Araújo VC; Juliano PB; Altemani A
    J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell adenoma and lymphoepithelial cyst as recurrent tumors of pleomorphic adenoma of the parotid gland.
    Kuratomi Y; Satoh S; Hayashida S; Inokuchi A
    Auris Nasus Larynx; 2006 Mar; 33(1):97-100. PubMed ID: 16171964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence tendency and malignant transformation of pleomorphic adenomas].
    Chilla R; Schneider K; Droese M
    HNO; 1986 Nov; 34(11):467-9. PubMed ID: 3027008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
    Mann W; Beck C; Karatay MC
    Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
    Soares AB; Altemani A; de Araújo VC
    J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between histopathology of pleomorphic adenoma in the parotid gland and recurrence after superficial parotidectomy.
    Park GC; Cho KJ; Kang J; Roh JL; Choi SH; Kim SY; Nam SY
    J Surg Oncol; 2012 Dec; 106(8):942-6. PubMed ID: 22740329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent pleomorphic adenoma of the parotid gland.
    Zbären P; Tschumi I; Nuyens M; Stauffer E
    Am J Surg; 2005 Feb; 189(2):203-7. PubMed ID: 15720991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A histological comparison of deep and superficial lobe pleomorphic adenomas of the parotid gland.
    Harney MS; Murphy C; Hone S; Toner M; Timon CV
    Head Neck; 2003 Aug; 25(8):649-53. PubMed ID: 12884348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors.
    Zbären P; Stauffer E
    Head Neck; 2007 Aug; 29(8):751-7. PubMed ID: 17252593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.